Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care

Project description

Novel diagnostic platform for virtual biopsy

The EU-funded MIRACLE project aims to develop an add-on device for magnetic resonance imaging (MRI) scanners to enable virtual biopsies, providing information on tumour margins for improving surgery and metabolic information for more effective therapies. This accurate and rapid non-invasive procedure will provide doctors with the information needed to create personalised treatment plans for given patients’ and tumour characteristics. The project partners’ previous research led to the development of an MRI coil for the non-invasive detection of metabolic biomarkers. The new project objective is to develop breast coil hardware and software, using breast cancer as a case study for evaluation.

Objective

Imagine a future where the limitless possibilities of virtual biopsies in cancer diagnostics can be explored. A future in which cancer patients would have access to MRI enabled virtual biopsies in order to receive the best possible treatment decisions anywhere on the globe. MIRACLE is developing a first-of-kind add-on device for MRI scanners that will be used to acquire a virtual biopsy of the tumor providing not only structural information on tumor dimensions for (tissue conserving) surgery, but also unique metabolic information on the efficacy of specific systemic therapies. Ultimately, this fully non-invasive, accurate and rapid predictive approach can guide patients to the best fitting treatment plan given their personal circumstances and tumor characteristics.
WaveTronica (WT) together with the University Medical Centre Utrecht (UMCU), German Cancer Research Centre (DKFZ) and Medical University of Lublin (UMLUB) aim to build this future by bringing the first Metabolic MRI-as-a-Service solution to the market. Past projects and research led to the development of a Proof-of-Concept MRI coil capable of detecting metabolic biomarkers non-invasively using the strongest clinically available MRI system, as demonstrated in FET- OPEN-01-2016-2017-801075 - the Non-Invasive-Chemistry-Imaging (NICI) and FET-OPEN-03-2018-2019-2020 - FET Innovation Launchpad - MIRACLE. The MRI coil is a plug-and-play add on for existing MRI machines resulting in an accessible and affordable virtual biopsy tool that can identify cancer biomarkers and tumor activity without shedding a drop of patient blood. This project converts a complex research tool into an accessible diagnostic service (Metabolic MRI-as-a-Service). MIRACLE is supported by the Dutch reimbursement company VGZ, Tesla DC, and oncologists showing there is a strong market demand. Now the challenge lies in bringing the breast coil PoC hardware and software to the next level using breast cancer as a use case.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-TRANSITIONOPEN-01

See all projects funded under this call

Coordinator

WAVETRONICA BV
Net EU contribution
€ 1 122 312,00
Address
PADUALAAN 8 ROOM Z109
3584 CH Utrecht
Netherlands
SME
Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 1 122 312,50

Participants (3)